Getein Biotech, Inc (SHA:603387)
China · Delayed Price · Currency is CNY 9.39
-0.04 (-0.42%)
Aug 14, 2026, 3:00 PM CST
Getein Biotech Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,075 | 1,052 | 1,165 | 1,369 | 1,822 | 1,402 |
Revenue Growth | -1.13% | -9.71% | -14.93% | -24.85% | 29.98% | 24.78% |
Gross Profit Gross Profit Growth | 711.93 | 712.11 | 776.73 | 889.45 | 1,150 | 916.29 |
Operating Income Operating Income Growth | 221.94 | 208.88 | 220.73 | 212.24 | 497.01 | 409.59 |
Net Income Net Income Growth | 232.66 | 220.66 | 223.64 | 279.77 | 498.91 | 398.99 |
Earnings Per Share EPS Growth | 0.46 | 0.44 | 0.44 | 0.55 | 0.98 | 0.78 |
EPS Growth | 15.32% | 0% | -20.00% | -43.88% | 25.64% | 30.00% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
China China Growth | 868.15 |
Foreign Foreign Growth | 183.56 |
Total Total Growth | 1,052 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,358 | 1,227 | 1,000 | 936.24 | 1,157 | 1,582 |
Total Debt Total Debt Growth | 401.72 | 481.96 | 581.57 | 666.68 | 591.02 | 496.44 |
Net Cash (Debt) Net Cash Growth | 956.12 | 744.54 | 418.9 | 269.56 | 566.37 | 1,085 |
Net Cash Growth | 257.26% | 77.74% | 55.40% | -52.41% | -47.81% | 7.27% |
Net Cash Per Share Net Cash Per Share Growth | 1.89 | 1.48 | 0.82 | 0.53 | 1.11 | 2.12 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 416.41 | 392.59 | 423 | 333.22 | 482.96 | 432.36 |
Capital Expenditures CapEx Growth | -135.16 | -150.58 | -156.4 | -258.13 | -217.44 | -179.6 |
Free Cash Flow Free Cash Flow Growth | 281.25 | 242.01 | 266.6 | 75.09 | 265.51 | 252.77 |
Free Cash Flow Growth | 17.90% | -9.22% | 255.02% | -71.72% | 5.04% | 251.38% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 66.22% | 67.71% | 66.68% | 64.96% | 63.14% | 65.37% |
Operating Margin | 20.64% | 19.86% | 18.95% | 15.50% | 27.28% | 29.22% |
Pretax Margin | 22.42% | 21.65% | 21.76% | 22.27% | 30.74% | 32.22% |
Profit Margin | 21.64% | 20.98% | 19.20% | 20.43% | 27.38% | 28.46% |
FCF Margin | 26.16% | 23.01% | 22.89% | 5.49% | 14.57% | 18.03% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.300 | 0.240 | 0.180 | 0.200 | 0.340 | 0.243 |
Dividend Per Share Growth | -16.67% | 33.33% | -10.00% | -41.18% | 39.98% | 32.30% |
Dividend Yield | 3.18% | 2.92% | 2.27% | 1.94% | 3.00% | 1.90% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 20.38 | 19.24 | 18.71 | 19.94 | 12.71 | 18.18 |
Forward PE | - | 17.43 | 17.43 | 17.43 | 17.43 | 17.43 |
P/FCF Ratio | 16.93 | 17.54 | 15.69 | 74.29 | 23.88 | 28.70 |
PS Ratio | 4.43 | 4.04 | 3.59 | 4.08 | 3.48 | 5.18 |